Journal Article

Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action

McFarland, James M., Geiger-Schuller, Kathryn, Rothberg, Michael, Ghandi, Mahmoud, Wolpin, Brian M., Aguirre, Andrew J., Roth, Jennifer A., Warren, Allison, Shibue, Tsukasa, Chambers, Emily, Golub, Todd R., Regev, Aviv, Paolella, Brenton R., Dionne, Danielle, Bender, Samantha, Rozenblatt-Rosen, Orit, Vazquez, Francisca, Tsherniak, Aviad, Tirosh, Itay, Kuksenko, Olena, Colgan, William N., Jones, Andrew

2020

Overview

Assays to study cancer cell responses to pharmacologic or genetic perturbations are typically restricted to using simple phenotypic readouts such as proliferation rate. Information-rich assays, such as gene-expression profiling, have generally not permitted efficient profiling of a given perturbation across multiple cellular contexts. Here, we develop MIX-Seq, a method for multiplexed transcriptional profiling of post-perturbation responses across a mixture of samples with single-cell resolution, using SNP-based computational demultiplexing of single-cell RNA-sequencing data. We show that MIX-Seq can be used to profile responses to chemical or genetic perturbations across pools of 100 or more cancer cell lines. We combine it with Cell Hashing to further multiplex additional experimental conditions, such as post-treatment time points or drug doses. Analyzing the high-content readout of scRNA-seq reveals both shared and context-specific transcriptional response components that can identify drug mechanism of action and enable prediction of long-term cell viability from short-term transcriptional responses to treatment. Large-scale screens of chemical and genetic vulnerabilities in cancer are typically limited to simple readouts of cell viability. Here, the authors develop a method for profiling post-perturbation transcriptional responses across large pools of cancer cell lines, enabling deep characterization of shared and context-specific responses.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 38 / 38/91 / 49 / 49/39 / 631/1647/2017 / 631/61/191/2018 / 631/67/69 / Antineoplastic Agents - pharmacology / Base Sequence / Biotechnology / Cancer / Cell Line, Tumor / Cell Survival - genetics / Cell viability / Computer applications / Context / Demultiplexing / Gene expression / Gene Expression Profiling - methods / Gene Expression Regulation, Neoplastic - drug effects / Gene sequencing / Humanities and Social Sciences / Humans / Models, Statistical / multidisciplinary / Multiplexing / Neoplasms - drug therapy / Neoplasms - genetics / Neoplasms - pathology / Perturbation / Polymorphism, Single Nucleotide / Pools / Pyridones - pharmacology / Pyrimidinones - pharmacology / Ribonucleic acid / RNA / Science / Science (multidisciplinary) / Single-Cell Analysis - methods / Single-nucleotide polymorphism / Transcription / Tumor cell lines